1. Home
  2. SNTG vs SHPH Comparison

SNTG vs SHPH Comparison

Compare SNTG & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sentage Holdings Inc.

SNTG

Sentage Holdings Inc.

HOLD

Current Price

$2.38

Market Cap

5.7M

Sector

Finance

ML Signal

HOLD

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.47

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNTG
SHPH
Founded
2009
2012
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
5.2M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
SNTG
SHPH
Price
$2.38
$0.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
38.3K
305.8K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$0.12
52 Week High
$12.70
$5.59

Technical Indicators

Market Signals
Indicator
SNTG
SHPH
Relative Strength Index (RSI) 57.65 34.56
Support Level $1.85 N/A
Resistance Level $2.50 $0.64
Average True Range (ATR) 0.24 0.06
MACD 0.03 0.00
Stochastic Oscillator 47.31 33.80

Price Performance

Historical Comparison
SNTG
SHPH

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider. The company offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

Share on Social Networks: